Health Condition 1: null- Patients of Type II Diabetes Mellitus diagnosed with diabetic peripheral sensorimotor neuropathy
Conditions
Interventions
Intervention1: Cap. Palsinuron: 2 Capsules twice daily after food with water
Intervention2: Cap. Palsinuron: 2 Capsules (360mg each) orally twice daily after food with water for three months
Control I
Sponsors
Ms SG Phyto Pharma Private Limited
Eligibility
Inclusion criteria
Inclusion criteria: 1. Metabolically stable diabetic patients with symptomatic diabetic sensorimotor polyneuropathy (DSPN) 2. Patients of either sex between the age group of 35-65 years. 3. HbA1c not exceeding 11
Exclusion criteria
Exclusion criteria: 1. Patients who are insulin dependent. 2. Patients with other metabolic and endocrinal disorders. 3. Patients with other causes of Polyneuropathy. 4. Patients suffering from infectious diseases. 5. Patients with non healing ulcer/ulcers. 6. Patients with Diabetic Polyneuropathy in stage N3 of Dyckâ??s staging
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| â?¢ Changes in Neuropathy Symptom Score (NSS) and â?¢ Michigan Neuropathy Screening Instrument (MNSI). â?¢ Quality of Life; WHO QoL (BREF) Timepoint: Baseline and at the end of 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of Life; WHO QoL (BREF)Timepoint: Baseline and at the end of 3 months | — |
Countries
India
Contacts
Public ContactDr Shreehari S Taklikar
Parul Institute of Ayurved Faculty of Ayurveda
Outcome results
None listed